Skip to content
Trial Eligibility
Menu

Early Age-Related Hearing Loss Investigation (EARHLI)

NCT06174038

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Early Age-Related Hearing Loss Investigation (EARHLI) is a single site study that will randomize late middle age adults to either a hearing intervention (including hearing aids) or a health education intervention. Participants will be followed for 1 year. This study will provide information on reducing cognitive decline in those at risk for Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD).

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Alzheimer Disease
  • Hearing Loss
  • Cognitive Impairment

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
55 to 75 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Columbia University
Last updated on ClinicalTrials.gov
August 12, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Columbia University Medical Center · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.